申请人:Pharmacia & Upjohn Company
公开号:US06084130A1
公开(公告)日:2000-07-04
Compounds and their pharmaceutically acceptable salts suitable for treating central nervous system disorders associated with the dopamine D3 receptor activity of structural Formula I: ##STR1##
结构式I中与多巴胺D3受体活性相关的治疗中枢神经系统疾病的化合物及其药用盐。